Literature DB >> 23001226

Nanoparticle immunotherapy: Combo combat.

C Jeffrey Brinker.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23001226     DOI： 10.1038/nmat3434

Source DB:  PubMed          Journal:  Nat Mater        ISSN： 1476-1122            Impact factor:   43.841


× No keyword cloud information.
  13 in total

1.  Nanotechnology in drug delivery and tissue engineering: from discovery to applications.

Authors:  Jinjun Shi; Alexander R Votruba; Omid C Farokhzad; Robert Langer
Journal:  Nano Lett       Date:  2010-09-08       Impact factor: 11.189

Review 2.  Recent advances with liposomes as pharmaceutical carriers.

Authors:  Vladimir P Torchilin
Journal:  Nat Rev Drug Discov       Date:  2005-02       Impact factor: 84.694

3.  CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.

Authors:  Mark J Smyth; Michele W L Teng; Jeremy Swann; Konstantinos Kyparissoudis; Dale I Godfrey; Yoshihiro Hayakawa
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

4.  Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15.

Authors:  Luciana V Carvalho; Rita de C Ruiz; Karina Scaramuzzi; Eliana B Marengo; Jivaldo R Matos; Denise V Tambourgi; Marcia C A Fantini; Osvaldo A Sant'Anna
Journal:  Vaccine       Date:  2010-10-25       Impact factor: 3.641

Review 5.  Transforming growth factor-beta and the immune response: implications for anticancer therapy.

Authors:  Stephen H Wrzesinski; Yisong Y Wan; Richard A Flavell
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

6.  Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer.

Authors:  Nicolas Acquavella; Harriet Kluger; John Rhee; Leonard Farber; Harold Tara; Stephan Ariyan; Deepak Narayan; William Kelly; Mario Sznol
Journal:  J Immunother       Date:  2008 Jul-Aug       Impact factor: 4.456

7.  Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy.

Authors:  Jason Park; Stephen H Wrzesinski; Eric Stern; Michael Look; Jason Criscione; Ragy Ragheb; Steven M Jay; Stacey L Demento; Atu Agawu; Paula Licona Limon; Anthony F Ferrandino; David Gonzalez; Ann Habermann; Richard A Flavell; Tarek M Fahmy
Journal:  Nat Mater       Date:  2012-07-15       Impact factor: 43.841

8.  Nanoparticles that communicate in vivo to amplify tumour targeting.

Authors:  Geoffrey von Maltzahn; Ji-Ho Park; Kevin Y Lin; Neetu Singh; Christian Schwöppe; Rolf Mesters; Wolfgang E Berdel; Erkki Ruoslahti; Michael J Sailor; Sangeeta N Bhatia
Journal:  Nat Mater       Date:  2011-06-19       Impact factor: 43.841

Review 9.  The polarization of immune cells in the tumour environment by TGFbeta.

Authors:  Richard A Flavell; Shomyseh Sanjabi; Stephen H Wrzesinski; Paula Licona-Limón
Journal:  Nat Rev Immunol       Date:  2010-07-09       Impact factor: 53.106

10.  Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling.

Authors:  Mitsunobu R Kano; Younsoo Bae; Caname Iwata; Yasuyuki Morishita; Masakazu Yashiro; Masako Oka; Tomoko Fujii; Akiyoshi Komuro; Kunihiko Kiyono; Michio Kaminishi; Kosei Hirakawa; Yasuyoshi Ouchi; Nobuhiro Nishiyama; Kazunori Kataoka; Kohei Miyazono
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-16       Impact factor: 12.779
View more
  7 in total

1.  Enhancing the anti-ovarian cancer activity of quercetin using a self-assembling micelle and thermosensitive hydrogel drug delivery system.

Authors:  Guangya Xu; Bin Li; Ting Wang; Jun Wan; Yan Zhang; Jingwei Huang; Yangmei Shen
Journal:  RSC Adv       Date:  2018-06-11       Impact factor: 4.036

Review 2.  Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma.

Authors:  Nathan B Roberts; Aniket S Wadajkar; Jeffrey A Winkles; Eduardo Davila; Anthony J Kim; Graeme F Woodworth
Journal:  Oncoimmunology       Date:  2016-08-19       Impact factor: 8.110

3.  Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles.

Authors:  Guangya Xu; Huashan Shi; Laibin Ren; Hongfeng Gou; Daoyin Gong; Xiang Gao; Ning Huang
Journal:  Int J Nanomedicine       Date:  2015-03-16

4.  Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles.

Authors:  Shoshy Mizrahy; Inbal Hazan-Halevy; Dalit Landesman-Milo; Brandon D Ng; Dan Peer
Journal:  Front Immunol       Date:  2017-02-06       Impact factor: 7.561

Review 5.  Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease.

Authors:  Dhruv R Seshadri; Anand Ramamurthi
Journal:  Front Pharmacol       Date:  2018-07-16       Impact factor: 5.810

6.  Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer.

Authors:  Xianli Hu; Bo Hou; Zhiai Xu; Madiha Saeed; Fang Sun; Zhenmei Gao; Yi Lai; Tong Zhu; Fan Zhang; Wen Zhang; Haijun Yu
Journal:  Adv Sci (Weinh)       Date:  2020-02-25       Impact factor: 16.806

Review 7.  Gold nanoparticle mediated cancer immunotherapy.

Authors:  Joao Paulo Mattos Almeida; Elizabeth Raquel Figueroa; Rebekah Anna Drezek
Journal:  Nanomedicine       Date:  2013-10-05       Impact factor: 5.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.